Work

Chasing EGFR Mutations in the Plasma of Patients With Resected NSCLC: Lessons in the ADAURA Era

Year: 2023

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.06.019

Authors: Francesco Facchinetti, Pasi A. Jänne, Marcello Tiseo

Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, University of Parma

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Les Laboratories Pierre Fabre, Arcus Foundation, Revolution Medicines, Fondation ARC pour la Recherche sur le Cancer, Astellas Pharma, Loxo Oncology

OpenAlex ID: W4385975559

FWCI: 0.161

Cites: 11

Cited by: 1

Related to: 10